Dave Johnson

2.3k total citations
11 papers, 274 citations indexed

About

Dave Johnson is a scholar working on Genetics, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Dave Johnson has authored 11 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Pathology and Forensic Medicine and 3 papers in Molecular Biology. Recurrent topics in Dave Johnson's work include Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Dave Johnson is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Dave Johnson collaborates with scholars based in United States, Germany and United Kingdom. Dave Johnson's co-authors include Brian J. Lannutti, Sarah Meadows, Volker Diehl, Adam Kashishian, Langdon L. Miller, Francisco Vega, Anas Younes, Arturo A. Ayón, C. Mauli Agrawal and Devang Patel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Cardiovascular Electrophysiology.

In The Last Decade

Dave Johnson

10 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dave Johnson United States 8 113 97 90 69 43 11 274
Keqin Yang China 11 39 0.3× 69 0.7× 47 0.5× 29 0.4× 35 0.8× 16 336
Shamudheen Mohammed Rafiyath United States 5 67 0.6× 115 1.2× 60 0.7× 102 1.5× 26 0.6× 7 432
Xiaolei Wei China 10 37 0.3× 69 0.7× 127 1.4× 148 2.1× 34 0.8× 38 341
Sachiyo Suzuki Japan 9 50 0.4× 112 1.2× 38 0.4× 31 0.4× 36 0.8× 14 467
Paul J. Hampel United States 11 221 2.0× 41 0.4× 149 1.7× 57 0.8× 86 2.0× 44 364
Lidan Zhu China 10 99 0.9× 130 1.3× 26 0.3× 74 1.1× 79 1.8× 31 375
Sarah May United States 7 161 1.4× 90 0.9× 105 1.2× 53 0.8× 78 1.8× 9 338
Zainul S. Hasanali United States 10 93 0.8× 78 0.8× 94 1.0× 70 1.0× 80 1.9× 24 313
Abraham Zepeda‐Moreno Mexico 11 23 0.2× 85 0.9× 37 0.4× 80 1.2× 54 1.3× 16 327
Pashna N. Munshi United States 9 46 0.4× 83 0.9× 112 1.2× 205 3.0× 32 0.7× 25 327

Countries citing papers authored by Dave Johnson

Since Specialization
Citations

This map shows the geographic impact of Dave Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dave Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dave Johnson more than expected).

Fields of papers citing papers by Dave Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dave Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dave Johnson. The network helps show where Dave Johnson may publish in the future.

Co-authorship network of co-authors of Dave Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Dave Johnson. A scholar is included among the top collaborators of Dave Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dave Johnson. Dave Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Jacobs, Victoria, Heidi T. May, Brian G. Crandall, et al.. (2018). Vagus nerve injury symptoms after catheter ablation for atrial fibrillation. Pacing and Clinical Electrophysiology. 41(4). 389–395. 7 indexed citations
2.
Rajasekaran, Narendiran, Idit Sagiv-Barfi, Serena Chang, et al.. (2014). Three BTK-Specific Inhibitors, in Contrast to Ibrutinib, Do Not Antagonize Rituximab-Dependent NK-Cell Mediated Cytotoxicity. Blood. 124(21). 3118–3118. 22 indexed citations
3.
Furman, Richard R., Jacqueline C. Barrientos, Jeff P. Sharman, et al.. (2012). A phase I/II study of the selective phosphatidylinositol 3-kinase-delta (PI3Kδ) inhibitor, GS-1101 (CAL-101), with ofatumumab in patients with previously treated chronic lymphocytic leukemia (CLL).. Journal of Clinical Oncology. 30(15_suppl). 6518–6518. 21 indexed citations
4.
Meadows, Sarah, Francisco Vega, Adam Kashishian, et al.. (2011). PI3Kδ inhibitor, GS-1101 (CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphoma. Blood. 119(8). 1897–1900. 116 indexed citations
6.
Johnson, Dave, Anil Mahapatro, Devang Patel, et al.. (2008). Drug Delivery from Therapeutic Self-Assembled Monolayers (T-SAMs) on 316L Stainless Steel. Current Topics in Medicinal Chemistry. 8(4). 281–289. 22 indexed citations
7.
Ayón, Arturo A., C. Mauli Agrawal, Marc D. Feldman, et al.. (2006). Drug loading of nanoporous TiO 2 films. Biomedical Materials. 1(4). L11–L15. 47 indexed citations
8.
Gruber, John B., et al.. (2006). Ligand‐field splitting of the energy levels of Nd3+ (4f3) in 2‐hydroxyethyl methacrylate polymer (HEMA). Polymer International. 55(9). 1007–1012. 2 indexed citations
9.
Phillips, M., Nurtan A. Esmen, Dave Johnson, et al.. (2001). 190. Permeability of Single-Family Dwellings: Implications for Indoor Air Quality. AIHce 2001. 190–190.
10.
Johnson, Dave, et al.. (1997). Reproducibility of Ventricular Fibrillation Characteristics in Patients Undergoing Implantable Cardioverter Defibrillator Implantation. Journal of Cardiovascular Electrophysiology. 8(11). 1209–1217. 15 indexed citations
11.
Mahendra, P, Dave Johnson, M. Scott, et al.. (1996). High-dose therapy and autologous stem cell rescue for poor risk and refractory lymphoma: a single centre experience of 123 patients.. PubMed. 17(6). 973–8. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026